EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis

Aprajita Srivastava, Anoop Saraya, Deepak Gunjan, Rinu Sharma iD

FEBS Open Bio · 2026

DOI: 10.1002/2211-5463.70167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von Aprajita Srivastava und 3 weiteren Autor:innen. Beteiligte Einrichtung: University School of Biotechnology, Guru Gobind Singh Indraprastha University, New Delhi, India. Hauptthemen laut MEDLINE: Esophageal Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India (SERB-DST), Guru Gobind Singh Indraprastha University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FGFRL1, one of the least explored FGFRs, has recently been shown to have implications in cancer, but its functional significance in esophageal cancer (EC) remains largely unexplored. We evaluated FGFRL1 expression in EC patients ( n = 106) using immunohistochemistry, observing a significant increase in preneoplastic and neoplastic tissues ( P < 0.001, OR = 73.2; AUC = 0.817). RNAi‐coupled next‐generation sequencing revealed enrichment of EMT, PI3K/Akt, and Notch pathways. Quantitative RT‐PCR validated the downregulation of top cluster and Notch pathway genes ( P < 0.05). Western blot showed decreased phospho‐GSK3β, phospho‐Akt, and mesenchymal markers. TCGA data supported a positive correlation with EMT. Functional assays demonstrated FGFRL1's oncogenic role, showing G1 phase arrest, and reduced proliferation, migration, and invasion ( P < 0.001). Our study highlights FGFRL1 as a key driver of EC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsHumansEpithelial-Mesenchymal TransitionSignal TransductionProto-Oncogene Proteins c-aktHigh-Throughput Nucleotide SequencingPhosphatidylinositol 3-KinasesDisease ProgressionFemaleMaleReceptors, NotchCell ProliferationGene Expression Regulation, NeoplasticMiddle AgedCell Line, TumorCell Movement

Stichwörter der Autor:innen

EMTFGFRclonogenicesophageal cancerinvasionsignalling

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesReceptors, Notch

Autor:innen und Institutionen

  • University School of Biotechnology, Guru Gobind Singh Indraprastha University, New Delhi, India.
  • Department of Gastroenterology, All India Institute of Medical Science, New Delhi, India.

ORCID-Profile: Rinu Sharma

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India (SERB-DST)
  • Guru Gobind Singh Indraprastha University

Zitieren

APA

Srivastava, A., Saraya, A., Gunjan, D., & Sharma, R. (2026). FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70167

Vancouver

Srivastava A, Saraya A, Gunjan D, Sharma R. FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70167

BibTeX
@article{Srivastava2026,
  author = {Srivastava, Aprajita and Saraya, Anoop and Gunjan, Deepak and Sharma, Rinu},
  title = {FGFR Like1 drives esophageal cancer progression via EMT , PI3K /Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis},
  journal = {FEBS Open Bio},
  year = {2026},
  doi = {10.1002/2211-5463.70167}
}
Kostenlos starten →